1. 3077 65 plus: A randomized phase III trial of Pemetrexed and Bevacizumab vs. Pemetrexed, Bevacizumab and Carboplatin as 1st line treatment for elderly patients with advanced non-squamous, non-small cell lung cancer (NSCLC) - a subgroup analysis of age and gender. (September 2015) Authors: Schuette, W.; Nieman, B.; Schneider, C.P.; Engel-Riedel, W.; Schumann, C.; Kohlhaeufl, M.; Serke, M.; Hoeffken, G.; Kortsik, C.; Reck, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗